^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG CLASS:

    RNA synthesis inhibitor

    Related drugs:
    Apply
    PM14 Administered Intravenously to Patients With Advanced Solid Tumors (NCT05076396)
    Phase 1
    PharmaMar
    Recruiting
    Last update posted :
    06/14/2024
    Initiation :
    09/06/2017
    Primary completion :
    08/13/2025
    Completion :
    08/13/2025
    BRCA
    |
    BRCA mutation
    |
    ecubectedin (PM14)
    DA Versus DAC as Postoperative Adjuvant Treatment for Early-stage Breast Cancer (NCT02838225)
    Phase 2
    Peking Union Medical College Hospital
    Completed
    Last update posted :
    07/20/2016
    Initiation :
    01/01/2009
    Primary completion :
    01/01/2016
    HER-2
    |
    paclitaxel • docetaxel • doxorubicin hydrochloride • cyclophosphamide • Pinorubin (pirarubicin) • cyclophosphamide intravenous